Drug intelligence / Profile preview

LomaHerpan

Development stage: Unknown
Lead developer: Infectopharm
Modality: Small Molecules
Administration: Topical

Overview

LomaHerpan is a topical herbal medicinal product developed by Infectopharm Arzneimittel GmbH for the treatment of herpes simplex labialis (cold sores). The active ingredient is a highly concentrated dry extract from lemon balm leaves (*Melissa officinalis*), with a drug-extract ratio of 65-75:1. It works by preventing the penetration of herpes simplex virus (types 1 and 2) into host cells, thereby limiting the spread of the lesion and reducing inflammatory symptoms such as redness, swelling, and blistering. Formulated as a cream, it is approved for use in children from age 3 and adults, and is notable for being suitable for use during pregnancy and breastfeeding.

Brand names: LomaHerpan
Other names: Melissa officinalis extractLemon balm extract

Beyond the preview

Go deeper on LomaHerpan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LomaHerpan.

Explore the full profile